Contribution of mathematical modeling to the fight against bacterial antibiotic resistance

Current Opinion in Infectious Diseases

Volumn 24, Issue 3, 2011, Pages 279-287

  Opatowski, Lulla ^a,b   Guillemot, Didier ^a,c,d   Boëlle, Pierre Yves ^e,f,g   Temime, Laura ^h  

^a INSTITUT PASTEUR   (France)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d RAYMOND POINCARÉ HOSPITAL   (France)

^e INSERM   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^h Bioinformatique et Chimie Moléculaire   (France)

Author keywords

bacterial resistance; epidemiology; intra host; mathematical modeling; population dynamic; transmission

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIAL TRANSMISSION; DECISION SUPPORT SYSTEM; DRUG USE; EPIDEMIOLOGICAL DATA; GENE MUTATION; GENE TRANSFER; HOST PATHOGEN INTERACTION; INFECTION RISK; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; NONHUMAN; PHENOTYPE; PRESCRIPTION; PUBLIC HEALTH; REVIEW;

EID: 79955521117     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283462362     Document Type: Review

References (105)

1. Ball P. Conclusions: the future of antimicrobial therapy - augmentin and beyond. Int J Antimicrob Agents 2007; 30:S139-S141.
2. Taubes G. The bacteria fight back. Science 2008; 321:356-361.
3. Morel CM, Mossialos E. Stoking the antibiotic pipeline. BMJ 2010; 340:c2115.
4. Austin DJ, Anderson RM. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Philos Trans R Soc Lond B Biol Sci 1999; 354:721-738. (Pubitemid 29365621)
5. Levin BR. Minimizing potential resistance: a population dynamics view. Clin Infect Dis 2001; 33:S161-S169. (Pubitemid 32835786)
6. Bonten MJ, Austin DJ, Lipsitch M. Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. Clin Infect Dis 2001; 33:1739-1746. (Pubitemid 33044542)
7. Hastings IM. Modelling parasite drug resistance: lessons for management and control strategies. Trop Med Int Health 2001; 6:883-890. (Pubitemid 33010874)
8. Peck SL. Antibiotic and insecticide resistance modeling: is it time to start talking? Trends Microbiol 2001; 9:286-292. (Pubitemid 32522809)
9. Bonovas S, Panagiotakos DB, Charalambides C, Vatopoulos A. Mathematical models for the evaluation of antibiotic resistance in hospitals: a systematic review. Cent Eur J Public Health 2003; 11:229-237. (Pubitemid 38141100)
10. Grundmann H, Hellriegel B. Mathematical modelling: a tool for hospital infection control. Lancet Infect Dis 2006; 6:39-45. (Pubitemid 41831376)
11. Temime L, Hejblum G, Setbon M, Valleron AJ. The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study. Epidemiol Infect 2008; 136:289-298. (Pubitemid 351233844)
12. Levin BR, Perrot V, Walker N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 2000; 154:985-997. (Pubitemid 30140690)
13. Garber AM. Antibiotic exposure and resistance in mixed bacterial populations. Theor Popul Biol 1987; 32:326-346.
14. Gerrish PJ, Garcia-Lerma JG. Mutation rate and the efficacy of antimicrobial drug treatment. Lancet Infect Dis 2003; 3:28-32. (Pubitemid 36041786)
15. Murphy JT, Walshe R, Devocelle M. A computational model of antibioticresistance mechanisms in methicillin-resistant Staphylococcus aureus (MRSA). J Theor Biol 2008; 254:284-293.
16. D?Agata EM, Dupont-Rouzeyrol M, Magal P, et al. The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteria. PLoS One 2008; 3:e4036.
17. MacLean RC, Hall AR, Perron GG, Buckling A. The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat Rev Genet 2010; 11:405-414.
18. Tanaka MM, Bergstrom CT, Levin BR. The evolution of mutator genes in bacterial populations: the roles of environmental change and timing. Genetics 2003; 164:843-854. (Pubitemid 36935664)
19. Iwasa Y, Michor F, Nowak MA. Evolutionary dynamics of invasion and escape. J Theor Biol 2004; 226:205-214. (Pubitemid 37468399)
20. Nikolaou M, Tam VH. A new modeling approach to the effect of antimicrobial agents on heterogeneous microbial populations. J Math Biol 2006; 52:154-182. (Pubitemid 43158380)
21. Michel JB, Yeh PJ, Chait R, et al. Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci USA 2008; 105:14918-14923.
22. Barlow M. What antimicrobial resistance has taught us about horizontal gene transfer. Methods Mol Biol 2009; 532:397-411.
23. Gehring R, Schumm P, Youssef M, Scoglio C. A network-based approach for resistance transmission in bacterial populations. J Theor Biol 2010; 262:97-106.
24. Levin BR. Microbiology. Noninherited resistance to antibiotics. Science 2004; 305:1578-1579.
25. Balaban NQ, Merrin J, Chait R, et al. Bacterial persistence as a phenotypic switch. Science 2004; 305:1622-1625. (Pubitemid 39296357)
26. Wiuff C, Zappala RM, Regoes RR, et al. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob Agents Chemother 2005; 49:1483-1494. (Pubitemid 40463380)
27. Levin BR, Rozen DE. Noninherited antibiotic resistance. Nat Rev Microbiol 2006; 4:556-562.
28. Roberts ME, Stewart PS. Modeling antibiotic tolerance in biofilms by accounting for nutrient limitation. Antimicrob Agents Chemother 2004; 48:48-52. (Pubitemid 38040175)
29. Roberts ME, Stewart PS. Modelling protection from antimicrobial agents in biofilms through the formation of persister cells. Microbiology 2005; 151:75-80. (Pubitemid 40207671)
30. Dodds MG, Grobe KJ, Stewart PS. Modeling biofilm antimicrobial resistance. Biotechnol Bioeng 2000; 68:456-465. (Pubitemid 30238859)
31. Cogan NG, Cortez R, Fauci L. Modeling physiological resistance in bacterial biofilms. Bull Math Biol 2005; 67:831-853. (Pubitemid 40707614)
32. De Gelder L, Ponciano JM, Abdo Z, et al. Combining mathematical models and statistical methods to understand and predict the dynamics of antibioticsensitive mutants in a population of resistant bacteria during experimental evolution. Genetics 2004; 168:1131-1144. (Pubitemid 40007337)
33. Campion JJ, Chung P, McNamara PJ, et al. Pharmacodynamic modeling of the evolution of levofloxacin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2005; 49:2189-2199. (Pubitemid 40734445)
34. Schulz zur Wiesch P, Engelstadter J, Bonhoeffer S. Compensation of fitness costs and reversibility of antibiotic resistance mutations. Antimicrob Agents Chemother 2010; 54:2085-2095.
35. Schrag SJ, Perrot V, Levin BR. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc Biol Sci 1997; 264:1287-1291. (Pubitemid 27445226)
36. Andersson DI. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol 2006; 9:461-465.
37. Austin DJ, Kakehashi M, Anderson RM. The transmission dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption. Proc Biol Sci 1997; 264:1629-1638. (Pubitemid 27504143)
38. Bonhoeffer S, Lipsitch M, Levin BR. Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci U S A 1997; 94:12106-12111. (Pubitemid 27467850)
39. Temime L, Boelle PY, Courvalin P, Guillemot D. Bacterial resistance to penicillin G by decreased affinity of penicillin-binding proteins: a mathematical model. Emerg Infect Dis 2003; 9:411-417. (Pubitemid 37070405)
40. Opatowski L, Mandel J, Varon E, et al. Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics. Antimicrob Agents Chemother 2010; 54:2330-2337.
41. Sun HR, Lu X, Ruan S. Qualitative analysis of models with different treatment protocols to prevent antibiotic resistance. Math Biosci 2010; 227:56-67.
42. Boni MF, Feldman MW. Evolution of antibiotic resistance by human and bacterial niche construction. Evolution 2005; 59:477-491. (Pubitemid 40441315)
43. Samore MH, Lipsitch M, Alder SC, et al. Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. Am J Epidemiol 2006; 163:160-170. (Pubitemid 43068985)
44. Van Effelterre T, Moore MR, Fierens F, et al. A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination. Vaccine 2010; 28:3650-3660.
45. Colijn C, Cohen T, Fraser C, et al. What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? J R Soc Interface 2010; 7:905-919.
46. Lipsitch M, Colijn C, Cohen T, et al. No coexistence for free: neutral null models for multistrain pathogens. Epidemics 2009; 1:2-13.
47. Lipsitch M. The rise and fall of antimicrobial resistance. Trends Microbiol 2001; 9:438-444. (Pubitemid 32844330)
48. Stewart FM, Antia R, Levin BR, et al. The population genetics of antibiotic resistance. II: Analytic theory for sustained populations of bacteria in a community of hosts. Theor Popul Biol 1998; 53:152-165. (Pubitemid 28417978)
49. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A 1999; 96:1152-1156. (Pubitemid 29072199)
50. Cohen T, Murray M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med 2004; 10:1117-1121. (Pubitemid 39424874)
51. Auranen K, Arjas E, Leino T, Takala A. Transmission of pneumococcal carriage in families: a latent Markov process model for binary longitudinal data. J Am Stat Assoc 2000; 95:1044-1053.
52. Melegaro A, Gay NJ, Medley GF. Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol Infect 2004; 132:433-441. (Pubitemid 38714119)
53. Cauchemez S, Temime L, Valleron AJ, et al. S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools. BMC Infect Dis 2006; 6:14.
54. Melegaro A, Choi Y, Pebody R, Gay N. Pneumococcal carriage in United Kingdom families: estimating serotype-specific transmission parameters from longitudinal data. Am J Epidemiol 2007; 166:228-235. (Pubitemid 47227292)
55. Jumbe N, Louie A, Leary R, et al. Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy. J Clin Invest 2003; 112:275-285. (Pubitemid 38056363)
56. Nikolaou M, Schilling AN, Vo G, et al. Modeling of microbial population responses to time-periodic concentrations of antimicrobial agents. Ann Biomed Eng 2007; 35:1458-1470. (Pubitemid 47115177)
57. Tam VH, Schilling AN, Poole K, Nikolaou M. Mathematical modelling response of Pseudomonas aeruginosa to meropenem. J Antimicrob Chemother 2007; 60:1302-1309. (Pubitemid 350168327)
58. Tam VH, Ledesma KR, Vo G, et al. Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development. Antimicrob Agents Chemother 2008; 52:3987-3993.
59. Lim TP, Ledesma KR, Chang KT, et al. Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2008; 52:2898-2904.
60. Regoes RR, Wiuff C, Zappala RM, et al. Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens. Antimicrob Agents Chemother 2004; 48:3670-3676. (Pubitemid 39304588)
61. Levin BR, Bonten MJ. Cycling antibiotics may not be good for your health. Proc Natl Acad Sci U S A 2004; 101:13101-13102. (Pubitemid 39209626)
62. Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis 2001; 32:1044-1054. (Pubitemid 32299640)
63. Lipsitch M, Bergstrom CT, Levin BR. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci U S A 2000; 97:1938-1943. (Pubitemid 30118547)
64. Bergstrom CT, Lo M, Lipsitch M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A 2004; 101:13285-13290. (Pubitemid 39209657)
65. Wang YC, Lipsitch M. Upgrading antibiotic use within a class: tradeoff between resistance and treatment success. Proc Natl Acad Sci U S A 2006; 103:9655-9660. (Pubitemid 43955880)
66. Opatowski L, Temime L, Varon E, et al. Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides. PLoS One 2008; 3:e2089.
67. Temime L, Guillemot D, Boelle PY. Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob Agents Chemother 2004; 48:2206-2213. (Pubitemid 38691620)
68. Temime L, Boelle PY, Valleron AJ, Guillemot D. Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection. Epidemiol Infect 2005; 133:493-501. (Pubitemid 40867686)
69. Andersson M, Ekdahl K, Molstad S, et al. Modelling the spread of penicillinresistant Streptococcus pneumoniae in day-care and evaluation of intervention. Stat Med 2005; 24:3593-3607. (Pubitemid 41700845)
70. Karlsson D, Jansson A, Normark BH, Nilsson P. An individual-based network model to evaluate interventions for controlling pneumococcal transmission. BMC Infect Dis 2008; 8:83.
71. Austin DJ, Bonten MJ, Weinstein RA, et al. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A 1999; 96:6908-6913. (Pubitemid 29274983)
72. Garber AM. A discrete-time model of the acquisition of antibiotic-resistant infections in hospitalized patients. Biometrics 1989; 45:797-816. (Pubitemid 19249322)
73. Sebille V, Chevret S, Valleron AJ. Modeling the spread of resistant nosocomial pathogens in an intensive-care unit. Infect Control Hosp Epidemiol 1997; 18:84-92. (Pubitemid 127469890)
74. Armeanu E, Bonten MJ. Control of vancomycin-resistant enterococci: one size fits all? Clin Infect Dis 2005; 41:210-216.
75. D?Agata EM, Horn MA, Webb GF. The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci. J Infect Dis 2002; 185:766-773. (Pubitemid 34226204)
76. D?Agata EM, Webb G, Horn M. A mathematical model quantifying the impact of antibiotic exposure and other interventions on the endemic prevalence of vancomycin-resistant enterococci. J Infect Dis 2005; 192:2004-2011. (Pubitemid 41681900)
77. D?Agata EM, Magal P, Olivier D, et al. Modeling antibiotic resistance in hospitals: the impact of minimizing treatment duration. J Theor Biol 2007; 249:487-499. (Pubitemid 350046634)
78. Smith DL, Dushoff J, Perencevich EN, et al. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci U S A 2004; 101:3709-3714. (Pubitemid 38344102)
79. Webb GF, D?Agata EM, Magal P, Ruan S. A model of antibiotic-resistant bacterial epidemics in hospitals. Proc Natl Acad Sci USA 2005; 102:13343-13348. (Pubitemid 41325025)
80. Cooper B, Lipsitch M. The analysis of hospital infection data using hidden Markov models. Biostatistics 2004; 5:223-237. (Pubitemid 41180225)
81. Forrester M, Pettitt AN. Use of stochastic epidemic modeling to quantify transmission rates of colonization with methicillin-resistant Staphylococcus aureus in an intensive care unit. Infect Control Hosp Epidemiol 2005; 26:598-606. (Pubitemid 41073399)
82. McBryde ES, Pettitt AN, Cooper BS, McElwain DL. Characterizing an outbreak of vancomycin-resistant enterococci using hidden Markov models. J R Soc Interface 2007; 4:745-754. (Pubitemid 47204173)
83. Pelupessy I, Bonten MJ, Diekmann O. How to assess the relative importance of different colonization routes of pathogens within hospital settings. Proc Natl Acad Sci U S A 2002; 99:5601-5605. (Pubitemid 34411595)
84. Perencevich EN, Fisman DN, Lipsitch M, et al. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units. Clin Infect Dis 2004; 38:1108-1115. (Pubitemid 38951256)
85. Wolkewitz M, Dettenkofer M, Bertz H, et al. Statistical epidemic modeling with hospital outbreak data. Stat Med 2008; 27:6522-6531.
86. Hotchkiss JR, Strike DG, Simonson DA, et al. An agent-based and spatially explicit model of pathogen dissemination in the intensive care unit. Crit Care Med 2005; 33:168-176; discussion 253-164. (Pubitemid 40116553)
87. Temime L, Opatowski L, Pannet Y, et al. Peripatetic health-care workers as potential superspreaders. Proc Natl Acad Sci U S A 2009; 106:18420-18425.
88. Temime L, Pannet Y, Kardas L, et al. NOSOSIM: an agent-based model of pathogen circulation in a hospital ward (session: agent-directed simulation). In: Proceedings of the 2009 Spring Simulation Multiconference; 2009; San Diego, California. San Diego, California, USA: Society for Computer Simulation International; 2009.
89. D?Agata EM, Webb GF, Horn MA, et al. Modeling the invasion of communityacquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 2009; 48:274-284.
90. Cooper BS, Medley GF, Stone SP, et al.Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci U S A 2004; 101:10223-10228. (Pubitemid 38898720)
91. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 1999; 5:336-345. (Pubitemid 29289447)
92. Campion JJ, McNamara PJ, Evans ME. Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2005; 49:209-219. (Pubitemid 40065795)
93. Restif O, Koella JC. Concurrent evolution of resistance and tolerance to pathogens. Am Nat 2004; 164:E90-E102.
94. Cooper BS, Medley GF, Bradley SJ, Scott GM. An augmented data method for the analysis of nosocomial infection data. Am J Epidemiol 2008; 168:548-557.
95. Grundmann H, Hori S, Winter B, et al. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis 2002; 185:481-488. (Pubitemid 34142810)
96. Sebille V, Valleron AJ. A computer simulation model for the spread of nosocomial infections caused by multidrug-resistant pathogens. Comput Biomed Res 1997; 30:307-322. (Pubitemid 27459741)
97. Massad E, Lundberg S, Yang HM. Modeling and simulating the evolution of resistance against antibiotics. Int J Biomed Comput 1993; 33:65-81. (Pubitemid 23210415)
98. Huang SS, Finkelstein JA, Lipsitch M. Modeling community- and individuallevel effects of child-care center attendance on pneumococcal carriage. Clin Infect Dis 2005; 40:1215-1222. (Pubitemid 40570227)
99. Blower SM, Chou T. Modeling the emergence of the ?hot zones?: tuberculosis and the amplification dynamics of drug resistance. Nat Med 2004; 10:1111-1116. (Pubitemid 39424873)
100. Geli P, Rolfhamre P, Almeida J, Ekdahl K. Modeling pneumococcal resistance to penicillin in southern Sweden using artificial neural networks. Microb Drug Resist 2006; 12:149-157. (Pubitemid 44784037)
101. Ferguson NM, Cummings DA, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in southeast Asia. Nature 2005; 437:209-214. (Pubitemid 41294478)
102. Edmunds WJ, Kafatos G, Wallinga J, Mossong JR. Mixing patterns and the spread of close-contact infectious diseases. Emerg Themes Epidemiol 2006; 3:10.
103. Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5:e74.
104. Zagheni E, Billari FC, Manfredi P, et al. Using time-use data to parameterize models for the spread of close-contact infectious diseases. Am J Epidemiol 2008; 168:1082-1090.
105. Mastering hOSpital Antimicrobial Resistance in Europe - MOSAR European Project Workpackage 8. https://www.mosar-sic.org/mosar/en-gb/our- activities/understand-transmission-of-resistance/understand-transmission- of-resistance accessed 24 March 2011).